Alkermes
ALKS
#2383
Rank
S$9.87 B
Marketcap
S$58.76
Share price
3.05%
Change (1 day)
38.31%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$3.20 Billion

According to Alkermes's latest financial reports the company's total liabilities are S$3.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$1.23 B-0.06%
2022-12-31S$1.23 B0.07%
2021-12-31S$1.23 B5.56%
2020-12-31S$1.16 B20.32%
2019-12-31S$0.97 B8.68%
2018-12-31S$0.89 B12.33%
2017-12-31S$0.79 B6.26%
2016-12-31S$0.74 B-2.32%
2015-12-31S$0.76 B11%
2014-12-31S$0.69 B
2013-03-31S$0.64 B-12.02%
2012-03-31S$0.73 B859.45%
2011-03-31S$76.14 M-47.08%
2010-03-31S$0.14 B-28.01%
2009-03-31S$0.19 B-58.71%
2008-03-31S$0.48 B-12.62%
2007-03-31S$0.55 B-23.32%
2006-03-31S$0.72 B30.14%
2005-03-31S$0.55 B71.2%
2004-03-31S$0.32 B-29.57%
2003-03-31S$0.46 B-0.52%
2002-03-31S$0.46 B4.97%
2001-03-31S$0.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$148.37 B 4,523.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$101.89 B 3,075.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$148.04 B 4,513.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$86.93 B 2,608.96%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$83.68 B 2,507.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$83.81 B 2,511.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
S$0.34 B-89.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$41.09 B 1,180.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel